Anebulo Pharmaceuticals Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
/ 
Frequently asked questions
To buy Anebulo Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Anebulo Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Anebulo Pharmaceuticals Inc. is ANEB:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Anebulo Pharmaceuticals Inc. has its primary listing on NASDAQ (Small cap). You can trade Anebulo Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Anebulo Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Anebulo Pharmaceuticals Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Anebulo Pharmaceuticals Inc..